From ulcerative colitis to amyloid storm: a case-based review

Sultan Özkurt1, Döndü Üsküdar Cansu2, Uygar Yildirim1

  • 1Division of Nephrology, Department of Internal Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey.

PubMed

Insights

Amyloid storm is a rare, acute kidney injury complication of AA amyloidosis, often triggered by infection. This case highlights ulcerative colitis as a cause, with high rates of end-stage renal disease and mortality.

Area of Science:

  • Nephrology
  • Rheumatology
  • Internal Medicine

Background:

  • Familial Mediterranean fever (FMF) complications include AA amyloidosis and amyloid nephropathy.
  • Amyloid storm is an acute presentation of AA amyloidosis with rapid renal failure.
  • It is rarely reported, often associated with FMF, but can be the initial manifestation of AA amyloidosis.

Purpose of the Study:

  • To report the first case of amyloid storm associated with ulcerative colitis.
  • To review the literature on amyloid storm, including causes, clinical features, and outcomes.
  • To highlight this rare but severe condition.

Main Methods:

  • Case presentation of a patient with ulcerative colitis and amyloid storm.
  • Literature review of 36 patients with amyloid storm.
  • Analysis of causes, triggering factors, end-stage renal disease (ESRD) rates, and mortality.

Main Results:

  • The reported case of amyloid storm was associated with ulcerative colitis, presenting with acute kidney injury and high proteinuria.
  • Literature review identified FMF as the most common cause (5.5%), but other conditions like ulcerative colitis, ankylosing spondylitis, and autoinflammatory diseases were noted.
  • Infections were the most common trigger; ESRD rates reached 67%, and mortality ranged from 33% to 67%.

Conclusions:

  • Amyloid storm is a critical, acute complication of AA amyloidosis with significant morbidity and mortality.
  • Ulcerative colitis is identified as a potential underlying cause.
  • Prompt recognition and management, including supportive care and IL-1 blockade, are crucial, though outcomes remain poor.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
739
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
626
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
943
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
448
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
528